Objectives: The Rochester criteria were developed to identify febrile infants aged 60 days or younger at low-risk of bacterial infection and do not include cerebrospinal fluid (CSF) testing. Prior studies have not specifically assessed criteria performance for bacteremia and bacterial meningitis (invasive bacterial infection). Our objective was to determine the sensitivity of the Rochester criteria for detection of invasive bacterial infection.
F
ebrile infants aged 60 days or younger are at high-risk of bacterial infections. [1] [2] [3] Bacteremia and bacterial meningitis (invasive bacterial infection) 4, 5 are less common than urinary tract infection (UTI) 3, 6 but are associated with high rates of mortality and neurologic morbidity. [7] [8] [9] [10] Clinical appearance alone is not adequate to identify febrile infants with invasive bacterial infection. 11 Therefore, febrile infants often undergo extensive laboratory testing, including lumbar puncture, to evaluate for bacteremia and meningitis. 12 However, the risk of missing a serious bacterial infection must be balanced with risks of this invasive testing, which include stress for families 13 and potentially unnecessary hospitalization and parenteral antibiotic treatment if the lumbar puncture is traumatic or unsuccessful. 14 Clinicians use varied published criteria to identify febrile infants at low-risk of bacterial infection who can safely be discharged home from the emergency department (ED). [15] [16] [17] The Rochester criteria were developed for febrile infants aged 60 days or younger and are the only published set of criteria that does not include the routine collection of cerebrospinal fluid (CSF). 17, 18 The Rochester criteria can therefore be used to identify low-risk infants who may not require lumbar puncture or hospitalization. Prior studies evaluating the Rochester criteria, however, were conducted at single centers and included only a small number of infants with bacteremia or meningitis. 17, 19, 20 In addition, the Rochester criteria were developed more than 20 years ago and should be reassessed in the era of widespread maternal prophylaxis against Group B streptococcus (GBS) 21 and conjugate vaccines for Streptococcus pneumoniae.
22
A recent executive summary by the Agency for Healthcare Research and Quality also highlighted that there are "insufficient data" on the ability of the low-risk criteria to detect bacteremia and bacterial meningitis in young febrile infants. 23 Our objectives were to describe the clinical characteristics of infants aged 60 days or younger with bacteremia and/or bacterial meningitis (invasive bacterial infection) presenting to 1 of 8 regionally diverse children's hospitals and to determine the sensitivity of the Rochester criteria for detection of invasive bacterial infection among febrile infants.
METHODS

Study Design
We performed a multicenter retrospective cohort study of infants aged 60 days or younger with culture-proven bacteremia and/or bacterial meningitis who were evaluated at 1 of 8 pediatric EDs between July 1, 2012, and June 30, 2014 (see Appendix, Supplemental Digital Content 1, http://links.lww.com/PEC/A258, for list of study sites and collaborators). Potential cases were identified using the Pediatric Health Information System (PHIS) and confirmed using medical record review at each study site. The study protocol was approved by the institutional review board at each participating site with a waiver of informed consent.
Study Protocol
Each of the 8 participating sites contribute data to PHIS, an administrative database affiliated with the Children's Hospital Association (Overland Park, Kan) that contains deidentified demographic, diagnosis, and billing data. 24 Potential cases of bacteremia and bacterial meningitis were identified by querying the PHIS database for all infants aged 60 days or younger evaluated at participating EDs with an International Classification of Diseases, Ninth Revision (ICD-9) discharge diagnosis for bacteremia or sepsis (771. 25 We also queried the PHIS database for all infants with an ICD-9 discharge diagnosis code for UTI or pyelonephritis (590.1, 590.2, 590.8, 599.0, or 771.82) 26 to identify infants with invasive bacterial infection and concomitant UTI. To further identify infants with bacteremia or meningitis who had only a diagnosis code assigned of fever, we additionally identified an equal number of randomly selected infants from the PHIS database over the same 2-year period (using a software-based randomizer) who had an ICD-9 admission or discharge diagnosis code for fever (780.6, 778.4, 780.60, or 780.61) 27 without associated ICD-9 diagnosis code for UTI, bacteremia, or meningitis and who had culture of urine, blood, or CSF obtained during the ED visit or hospitalization. We excluded infants with a complex chronic condition, 28 as these infants may undergo a nonstandard evaluation, as well as infants transferred from another hospital as the infant may have undergone testing or treatment prior to transfer. A total of 1057 potential cases were identified using the described search strategy.
We then used medical record review to confirm the presence of culture-positive bacteremia and/or bacterial meningitis among these potential cases. For the infants with confirmed culturepositive bacteremia and/or meningitis on medical record review, data collected included medical history, physical examination findings, and results of laboratory testing including urine, blood, and CSF cultures. Data abstraction for medical record review at each of the 8 study sites was performed using the REDCap (Research Electronic Data Capture) tool hosted at the University of Washington. 29 We abstracted the following demographics from the PHIS database: age, sex, and race/ethnicity (non-Hispanic white, nonHispanic black, Hispanic, Asian, or other). To determine the prevalence of infants with invasive bacterial infection among the broader population of infants undergoing diagnostic testing, from the PHIS database we also extracted the total number of infants 60 days or younger in whom a blood culture or CSF testing was performed using the same exclusion criteria described previously.
Rochester Criteria
The Rochester criteria identify febrile infants aged 60 days or younger at low-risk of bacterial infection if they satisfy all of the following criteria: (1) well appearing, (2) born at ≥37 weeks' gestation and previously healthy, (3) no source of infection present on examination, (4) peripheral white blood cell (WBC) count 5000 to 15,000/μL, (5) absolute band count 1500/μL or less, and (6) WBCs 10 or less on urine microscopy. 17 We defined fever as a documented temperature of 100.4°F or greater (38.0°C) at home or in the ED. 30 The Rochester criteria were applied to all infants aged 60 days or younger with fever in the study cohort based on medical record review.
For our study, we defined "ill appearance" as "symptomatic or ill appearing" based on the following medical record review inquiry: "Were there any findings on examination to suggest that the patient was symptomatic or ill appearing?" (categorized as yes or no). If yes, the patients were further categorized based on the presence or absence of the following features: hypotension, tachycardia (heart rate >160 beats/min during ED course), tachypnea (respiratory rate >50 breaths/min), increased work of breathing, grunting, mental status changes (somnolence, lethargy, irritability, seizures), or other (with a description).
An infant was determined to not have been previously healthy if any of the following were present: prematurity at less than 37 weeks' gestation at birth, prior antibiotic exposure or hospitalization not including the newborn hospitalization, prior sepsis evaluation for fever, or the presence of immunodeficiency; urinary tract, neurologic, or gastrointestinal abnormality; or other severe or chronic condition. Two of the 8 participating hospitals do not report bands as a component of the complete blood count (CBC); therefore, band count was reported only for infants from 6 hospitals. For sites at which automated differentials were performed, a priori the band count was recorded as "not reported" if no bands were reported on the CBC; for the 2 hospitals that do not report bands, "N/A" was documented. Cerebrospinal fluid pleocytosis was defined as 10 WBCs/high-power field or greater. 31 
Outcome Measures
Our primary outcome was invasive bacterial infection defined as either bacteremia or bacterial meningitis. We defined bacteremia as growth of a bacterial pathogen from blood culture and bacterial meningitis as growth of a pathogenic species from CSF culture (determined a priori by consensus of the 2 board-certified pediatric infectious diseases physicians in the Febrile Young Infant Research Collaborative). 32 In addition, cultures that grew common contaminant bacteria were treated as contaminants 32 unless the bacterial species was isolated from 2 sites (urine, blood, and/or CSF) and treated as a pathogen; these were included as a pathogen species. Infants with bacteremia and CSF pleocytosis, but with negative CSF culture after antibiotic pretreatment, were defined as bacteremia as per our a priori definition.
Statistical Analysis
We described characteristics of infants with bacteremia and/or meningitis overall and in 2 distinct age groups: 28 days or younger and 29 to 60 days of age. Categorical variables were described using frequencies with 95% confidence intervals (CIs). After retrospective application of the Rochester criteria to the febrile infants aged 60 days or younger, we calculated the sensitivity for invasive bacterial infections.
RESULTS
Patient Characteristics
Of the 5011 infants aged 60 days or younger who underwent blood culture in the 8 EDs during the 2-year study period, 85 (1.7%) had culture-positive bacteremia. Of 3381 infants who had CSF obtained, 10 (0.3%) had culture-positive bacterial meningitis, including 6 with concomitant bacteremia. Fifty-three (59.6%) of the 89 infants with invasive bacterial infection were 28 days or younger, and 36 (40.4%) were 29 to 60 days of age. Nine (90.0%) of the 10 infants with meningitis were 28 days or younger (Table 1) .
Invasive Bacterial Infection
Overall, 43 (48.3%) of the 89 infants with invasive bacterial infection were symptomatic or ill appearing on presentation; 11 infants had only tachycardia as a symptom. Of the 7 infants who did not have fever on presentation, 6 (85.7%) were symptomatic or ill appearing including 2 with hypothermia of less than 36.0°C; 1 well appearing 3-day-old infant was subsequently diagnosed as having bacteremia during a hospitalization for hyperbilirubinemia. Of the 82 febrile infants with invasive bacterial infection (including all 10 with meningitis), 58 (70.7%) were either symptomatic/ill appearing or had an abnormal peripheral WBC or absolute band count as per the Rochester criteria (Table 2) . Two febrile neonates 28 days or younger had bacteremia with CSF pleocytosis, but negative CSF cultures after antibiotic pretreatment.
Nine of the 10 infants with bacterial meningitis were described as symptomatic or ill appearing on presentation, including the 1 infant older than 28 days who had mental status changes (Tables 2 and 3 ). Two infants with meningitis 28 days or younger were determined to be symptomatic or ill appearing because of tachycardia only, including one 13-day old with GBS bacteremia and meningitis who had a heart rate of 198 beats/min with a normal urinalysis and peripheral WBC count, with no band cells reported. The 1 patient who was not symptomatic or ill appearing was a 19-day-old infant with Paenibacillus bacteremia and meningitis who had a normal peripheral WBC count and absolute band count that met lowrisk Rochester criteria (Table 3) .
Rochester Criteria
The sensitivity of the Rochester criteria for identification of febrile infants aged 60 days or younger with invasive bacterial infection was 92.7% (95% CI, 84.9%-96.6%). Among febrile infants aged 28 days or younger, the sensitivity was 91.7% (95% CI, *Gestational age at less than 37 weeks, prior hospitalization or antibiotics, prior sepsis evaluation for fever, immunodeficiency, urinary tract abnormality prior to ED visit, neurologic abnormality, gastrointestinal abnormality, or other severe or chronic condition. † Three patients with bacteremia and 2 patients with bacterial meningitis did not have a urinalysis obtained. ‡ Two of 8 hospitals do not report band count; denominator comprises all infants at the remaining 6 hospitals, including those infants with band count "not reported." § Abnormal WBC/band count defined as peripheral WBCs greater than 15,000/μL or less than 5000/μL or absolute band count greater than 1500/μL. 80.5%-96.7%) and was 94.1% (95% CI, 80.9%-98.4%) for infants aged 29 to 60 days of age.
Four febrile infants, including two 28 days or younger (1 patient with meningitis), would not have been classified as low-risk based solely on the presence of tachycardia. Reclassification of these infants as low-risk would lower the sensitivity of the Rochester criteria to 87.8% (95% CI, 80.0%-93.2%) for invasive bacterial infection.
Six febrile infants with bacteremia, including 1 infant with meningitis, would have been classified as low-risk by the Rochester criteria (Table 4) . Three of the infants aged 28 days or younger had a CSF pleocytosis, and another had low-level pyuria on urinalysis (6-10 WBCs/high-power field). The 4 neonates 28 days or younger received empiric intravenous antibiotic therapy, whereas the 2 infants aged 29 to 60 days received ceftriaxone prior to ED discharge and were subsequently hospitalized when their blood cultures resulted as positive (Table 4) .
DISCUSSION
We performed a multicenter validation of the Rochester criteria for identification of bacteremia and bacterial meningitis. While clinical appearance and CBC alone should not be used to determine the presence of invasive bacterial infection among febrile young infants, with application of the Rochester criteria, 92% of febrile infants aged 60 days or younger with bacteremia and/or meningitis would have been classified as non-low-risk. In addition, 9 of 10 infants with bacterial meningitis were symptomatic or ill appearing, including the 1 infant older than 28 days. However, although the criteria performed similarly among neonates As a result, clinicians should be cautious in the application of the Rochester criteria to infants in the first month of life without performance of lumbar puncture.
The majority of infants aged 60 days or younger with bacteremia were described as well appearing, and nearly one-third of these infants also had no evidence of infection on CBC based on a WBC of 5000 to 15,000/μL and an absolute band count 1500/μL or less (when obtained). Our findings are consistent with prior investigations that demonstrate that well appearance 11 and normal serum leukocyte counts 33 are not sensitive for the detection of bacteremia in febrile young infants when used in isolation.
The sensitivity of the Rochester criteria for identification of bacteremia and/or meningitis was 92.7%, similar among infants aged 29 to 60 days of age and those 28 days or younger. Prior studies of the Rochester criteria reported sensitivity of 92.4% to 96.7%, 17, 20 although the majority of the bacterial infections in these studies were UTIs. When only bacteremia and meningitis were included, the sensitivity was 84.6% to 85.7%, 17, 20 although there were fewer than 15 cases of bacteremia in each study. Biondi et al 32 reported a sensitivity of 80% for bacteremia in a recent multicenter cohort, although their aim was to assess differences in epidemiology based on risk status, not to specifically evaluate the Rochester criteria. In addition, the performance of the Rochester criteria for detection of meningitis was not assessed. 32 When the 4 febrile infants in our study with tachycardia as their only symptom were reclassified as low-risk, the sensitivity of the Rochester criteria was similar to these prior investigations at 87.8%. Tachycardia has been reported as a predictor of bacterial infection and sepsis in children, although data are limited for infants younger than 3 months. 34, 35 The presence of tachycardia as an isolated predictor of invasive bacterial infection should be further explored, as this finding may be commonly observed among febrile infants without bacteremia and/or meningitis and therefore would likely lower the specificity of the Rochester criteria to achieve higher sensitivity.
Although the lack of 100% sensitivity of the Rochester criteria for identification of invasive bacterial infection may be of concern to clinicians, the sensitivity reported is similar to or higher than other diagnostic tools being investigated for detection of invasive bacterial infection in young infants, including procalcitonin. 4, 5 In addition, low-risk infants with invasive bacterial infections have been previously reported to do well with outpatient follow-up, 36 although we were unable to meaningfully assess outcomes in this current study as all 6 low-risk infants received empiric antibiotic treatment. Overall, both bacteremia and meningitis were very uncommon among infants who underwent blood culture or CSF testing during the study period, and "missed" infants therefore comprised a low percentage of the entire population. Although we were not able to assess the negative predictive value of the Rochester criteria, prior studies have demonstrated high negative predictive value among all febrile infants given the rarity of invasive bacterial infections. 17, 20 The low, but present, risk of missing a young infant with bacteremia with application of the Rochester criteria must be weighed against the parental stress 13 and potential risks involved with hospitalization and antibiotic administration, 23 particularly for infants aged 29 to 60 days. Low-risk febrile neonates 28 days or younger are routinely admitted and empirically treated. [37] [38] [39] Although the Rochester criteria identified most neonates with invasive bacterial infections, further study is needed to examine outcomes of lowrisk infants in this age group who are admitted off antibiotics or discharged home with close follow-up. Although CSF testing is not part of the Rochester criteria, all 4 infants 28 days or younger with bacteremia classified as low-risk would have been identified by CSF pleocytosis with lumbar puncture, which is obtained routinely in this age group, 37, 38 or by lower threshold of pyuria on urinalysis as used in prior studies. 40, 41 Among infants who underwent CSF testing during the study period, bacterial meningitis was rare and usually associated with symptoms or ill appearance, especially among infants older than 28 days. Greenhow et al 6 reported that 10 of 16 infants 90 days or younger with bacterial meningitis were ill appearing, although they used a strict definition of ill appearance and did not specify the age or laboratory values of the 6 infants who were well appearing. As bacterial meningitis is very rare among infants 29 to 60 days of age, and the 1 infant with meningitis in this study had mental status changes, our findings support guidelines of selective CSF testing for these older febrile infants. 39 However, the wide CIs for the sensitivity of the Rochester criteria for detection of bacterial meningitis reflect our small sample size; a larger study would be needed for a more precise estimate of sensitivity. Importantly, 1 febrile infant 28 days or younger with bacterial meningitis would have been missed using the Rochester criteria, and another infant had only tachycardia as a high-risk symptom. These infants and the higher rate of meningitis in this age group support the widely adopted practice of routine CSF testing in neonates. 38, 39 Our study has several limitations. For case identification, we searched an administrative database using ICD-9 diagnosis codes. It is therefore possible that we did not identify all cases of bacteremia and meningitis if an ICD-9 diagnosis code was not attributed to the encounter. However, we used a broad search strategy that included ICD-9 codes for UTI and fever to identify infants with bacteremia or meningitis, in whom an accompanying diagnosis code was not present. In addition, we excluded patients transferred from another institution, as we were unable to ascertain laboratory testing in these patients. We also excluded children with complex chronic conditions; however, these conditions would often result in a non-low-risk classification using the Rochester criteria. Also, our study was conducted within EDs of tertiary care children's hospitals, and our findings may not be generalizable to other practice settings.
The study also has several limitations in the application of the Rochester criteria. First, the presence of fever, as well as clinical appearance and medical history (including prematurity and the Rochester criteria definition of "previous healthy"), may not be accurately documented in the medical record. We also applied the Rochester criteria to infants from all 8 participating hospitals, including 2 hospitals that do not report peripheral bands. However, all but 1 infant at these 2 hospitals were classified as non-low risk without a reported band count.
CONCLUSIONS
Approximately 92% of infants with bacteremia and/or meningitis were accurately identified by the Rochester criteria. Among infants aged 60 days or younger, bacterial meningitis was rare and usually associated with symptoms or ill appearance, especially among infants older than 28 days. However, a few infants 28 days or younger with invasive bacterial infections, including 1 infant with bacterial meningitis, were well appearing and classified as low-risk by the Rochester criteria. Clinicians should be cautious in use of the Rochester criteria in febrile neonates 28 days or younger without performance of lumbar puncture, pending further investigation on outcomes of low-risk infants with invasive bacterial infections.
